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GLOSSARY
MTP - Medical Termination of Pregnancy
UMP - Unmarried Pregnanacy
GA - Gestational Age
I-A - Induction – Abortion Interval
µg - Microgram 











Historically,  pregnancies  were   terminated   through a  number of  methods 
including   the   administration   of   abortifacient   herbs,   the   use   of   sharpened 
instruments,   camel   dung,   the   application   of   abdominal   pressure   and   other 
techniques.
1
Soranus,   a   second   century   Greek   physician,   suggested   in   his   work 
Gynecology   that  women  wishing   to   abort   their   pregnancies   should   engage   in 
violent exercise, energetic jumping, carrying heavy objects and riding animals.




and an  abortifacient.  Such folk   remedies,  however  varied   in  effectiveness  and 
were   not  without   risks.  Tansy  and  Pennyroyal  are   two  poisonous   herbs  with 
serious side effects that have at times been used to terminate pregnancies.



















































































When   continuation   of   pregnancy   is   likely   to   endanger   the   life   of   the 
pregnant women.
                       Cause grievous injury to her physical and medical health as in case of 














































In countries  with liberal  abortion  laws maternal morbidity  and mortality 
have declined and women have been motivated to accept birth control measures 
(World Health Organization).
Repeated abortions  are not  conducive  to  a woman’s  health,  hence MTP 
should not be considered as a birth control measure and should not replace the 
prevailing methods of contraception.






























































Misoprostol   is  metabolically resistant and thus has prolonged action For 
induction  of  abortion,  misoprostol   is  as  effective  as  gemeprost  and  is  a  better 
alternative than mifepristone 
PHARMACOKINETICS:




















































and   55%   for   5­7  week   group   and   67%   for   8­11  week   group   receiving   400 
microgram.
(Bugalho et al, 1996) (17)
Crenin(18)   and   Vittinghoff  tried   800  microgram   of  misoprostol   up   to 
maximum total dose of 1600 microgram vaginally 24 hours apart with pregnancies 
less than or equal to 56 days gestation and showed success rate of 47%.



















upon  the  amount  of   remains  present   in   the  uterus  as  determined by 
ultrasound and showed a success rate of 94%.
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three   to   four   hours   before   surgical   termination   of   first   trimester   pregnancies 
concluded that vaginal misoprostol was as effective as gemeprost.
22
Norman   et   al   1991,(22)  conducted   a   study   using   single   dose   of   400 
microgram of misoprostol  with a success rate of only 5%.
Study by zikopoulos KA, Papanikolaou EG et al using 800 microgram of 






                            METHOTREXATE:
Methotrexate (both oral and intramuscular combined with misoprostol have 














It   is   an   anti­progestin,   acts   by   binding  with   progesterone   receptor   and 
inhibits the action of progestin, hence interfere with continuation of pregnancy.
After  confirming   the  eligibility   to  undergo medical  abortion  600 mg of 
mifepristone is administered orally on day 1.
24
     On day 3,  the patient  is assessed for the possibility of pregnancy expulsion 
which occurs only in 2­5% of patients with mifepristone alone.
MIFEPRISTONE WITH PROSTAGLANDIN ANALOGUES







































































































































1 <20 7 7 9 9 7 7
2 21­25 37 37 38 38 35 35
3 26­30 40 40 42 42 43 43





















1 UMP 2 2 1 1 2 2
2 G1 16 16 14 14 14 14
3 G2 39 39 43 43 44 44
























0 0 2 2 4 4
2 Class III 12 12 13 13 10 10






















1 < 7 Weeks 10 10 6 6 8 8
2 7­9 Weeks 20 20 22 22 16 16
3 10­12 
Weeks

































































































































































































200 41 22.22 .613 24 21
400 52 19.57 .936 22 18





































































• Mean   induction­   abortion   interval   is   20.90,   18.61,   18.53   and   19.16   in 
unmarried  pregnancy,   primigravida,   second  gravidae   and   third   gravidae 
respectively. By Statistical analysis of induction abortion interval, there is 













41 52 74 0.01
2 Incomplete 
Abortion













































































400   microgram   and   600   microgram   groups 
respectively.
The   success   rates   were   different   in   different 
studies  using  different   route  of  administration 





800µg   [Esteve  JL  et   al   1998]   at   24   hours 
interval.
Success   rate   is   97%  complete   abortion   using 
800   microgram   at   24   hours   interval  (Jain,  
Mekstroth, Lacarra 1998)
49







had   vomiting.     Other   side   effects   reported   were 





In   this   study  400  µg  group  women experienced   the 
following side effects viz., vomiting (35%), excessive 
50
bleeding   (25%)   abdominal   cramps   (18%),   diarrhea 
(2%) and Dizziness (1%)
When compared to other two groups 41% of women in 
600   µg   group   experienced   vomiting,   16%   uterine 
cramps, 5% diarrhea and 2% dizziness.
Various studies conducted by Carbonell et al  [1999 – 
2000]   using   different   doses   at   different   intervals 
showed varying side effects.
Nausea   (22%),   vomiting   (17%),   diarrhea   (54%), 
dizziness (25%), Headache (19%), fever (26%), pelvic 




























rate   of   complete   and   incomplete   abortions   with   a 
p value of 0.01 and 0.05
  A WHO multicentric trial  (1998 ­2000) using three 











In   a   study   by   Mittal,   Kumar   et   al   more   women 
experienced   vaginal   bleeding,   abdominal   pain   and 










                 The efficacy of three regimens of vaginal misoprostol was compared in 









































where   infrastructural   facilities   and   trained  personnel   are   at   a   premium. 
However, there is scope for misuse of this drug which needs to be curtailed 
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OBSTETRIC FORMULA: G P L A
H/O PREVIOUS MTP DONE:
1. HOW MANY WEEKS
2. METHOD ADOPTED




 FAILURE OF CONTRACEPTION
 UNWED PREGNANCY
 MEDICAL REASONS
PAST MEDICAL / SURGICAL HISTORY
H/O DIABETES HYPERTENSION / PULMANORY TUBERCULOSIS / 
BRONCHIAL  ASTHMA  /  EPILEPSY  /  HEART  DISEASE  /  ENDOCRINE 
DISORDER / ALERGY TO DRUG.
ON EXAMINATION:
GENERAL
ANAEMIA YES / NO
FEBRILE YES / N O


















DATE / TIME OF ADMINISTRATION OF VAGINAL, MISOPROSTOL (200 
μg, 400 μg, 600 μg) 
TIME OF EXPULSION: COMPLETE / IN COMPLETE:
67







5. ABDOMINAL PAIN / UTERINE CRAMPS
TOTAL INDUCTION ABORTION INTERVAL
68
